Aspirin for the Primary Prevention of Cardiovascular Events: An Update of the Evidence for the U.S. Preventive Services Task Force

  1. Tracy Wolff, MD, MPH;
  2. Therese Miller, DrPH; and
  3. Stephen Ko, MD, MPH
  1. From the Agency for Healthcare Research and Quality, Rockville, Maryland, and New York Presbyterian Hospital–Cornell, New York, New York.
    1. Figure 1.
      View larger version:
        Figure 1. Analytic framework: aspirin to prevent cardiovascular events.

        CHD = coronary heart disease; CVD = cardiovascular disease; GI = gastrointestinal; KQ = key question.

      • Figure 2.
        View larger version:
          Figure 2. Study flow diagram.

        Responses to this article

        • Aspirin for the essential arterial hypertension
          • Hernando Rafael
          Ann Intern Med published online October 26, 2009

        Summary for Patients

        • Summaries for Patients:Aspirin for the Prevention of Cardiovascular Disease: U.S. Preventive Services Task Force Recommendation Statement Ann Intern Med March 17, 2009 150:I-37; doi:10.1059/0003-4819-150-6-200903170-00003
        « Previous | Next Article »Table of Contents

        This Article

        1. Ann Intern Med March 17, 2009 vol. 150 no. 6 405-410
        1. AbstractFREE
        2. » Figures
        3. Full Text
        4. Full Text (PDF)
          1. Summary for Patients
        6. Recommendation Summary

        Current Issue

        1. November 17, 2009, 151 (10)
        1. Alert me to current issues